InVivo Therapeutics released the 12-month results of its investigational study of the Neuro-Spinal Scaffold to treat acute thoracic complete spinal cord injury. By Shayna Korol - 8/28/18

Avista Healthcare Public Acquisition will merge with the regenerative medicine company Organogenesis. By Shayna Korol - 8/27/18

Isto Biologics is an orthobiologics company that develops spine and orthopedic solutions. By Shayna Korol - 8/22/18

Axial spondyloarthritis patients who received biologics-based treatment had less work and activity impairment than patients who did not receive biologics, according to a study in the Annals of the Rheumatic Diseases. By Shayna Korol - 8/21/18

Dr. Jonathan Hopper joined Vericel Corp., as the company's new CMO. By Jackie Drees - 8/20/18

The global spine biologics market is expected to grow at a 4.4 percent compound annual growth rate to reach more than $2.6 billion by 2022, according to a Market Research Engine report. By Shayna Korol - 8/20/18

Paragon 28 released its bone graft harvesting system, which is designed to improve foot and ankle surgical outcomes. By Jackie Drees - 8/16/18

BioRestorative Therapies' study, which evaluates the benefits of long-term hypoxic culturing of human bone marrow-dervied mesenchymal stem cells to treat disc and spine diseases, was published in the Journal of Translational Medicine. By Jackie Drees - 8/16/18

The Steadman Philippon Research Institute's fourth annual Vail Scientific Summit is Aug. 19-21 in Vail, Colo., and it will focus on the clinical advances made in the study of biologics and cell therapy. By Jackie Drees - 8/15/18

Minneapolis-based University of Minnesota researchers used 3D-printing technology to print stem cell-infused scaffolds that may be implanted in spinal cords to alleviate nerve damage, the StarTribune reports. By Mackenzie Garrity - 8/10/18

Co-Founder of the New York Cartilage Repair Society Eric Strauss, MD, an orthopedic surgeon with New York City-based NYU Langone Health, discusses the society and biggest trends in cartilage repair today. By Laura Dyrda - 8/10/18

The global spine biologics market is predicted to reach $2.7 billion by 2024, growing at a 4.4 percent compound annual growth rate, according to a Data Bridge Market Research report. By Shayna Korol - 8/9/18

Researchers at Central Queensland University in Australia are developing a 3D bioprint of crocodile cartilage to promote cartilage repair, ABC Capricornia reports. By Shayna Korol - 8/8/18

UC San Diego researchers successfully derived spinal cord neural stem cells from human pluripotent stem cells, according to research published in Nature Methods. By Shayna Korol - 8/8/18

To meet the growing demand for alternatives to spinal fusion, Kevin Pauza, MD, certified 14 spine specialists to perform the Discseel procedure at Weill Cornell Brain and Spine Center in New York City. By Mackenzie Garrity - 8/7/18

The global platelet rich plasma market is projected to increase from 2018 through 2026 at a 13.3 percent compound annual growth rate, according to a Credence Research report. By Shayna Korol - 8/6/18

Pete O'Heeron is the founder and CEO of SpinalCyte. By Shayna Korol - 8/6/18

Aziyo Biologics will exclusively distribute its bone repair product ViBone through RTI Surgical in the U.S. By Shayna Korol - 8/2/18

Asterias Biotherapeutics provided an update from its ongoing phase 1/2a clinical trial of a stem cell treatment for severe spinal cord injury. By Shayna Korol - 8/1/18

Ortho Regenerative Technologies earned extensions of expiry dates on certain warrants. By Mackenzie Garrity - 8/1/18